Format

Send to

Choose Destination
J Assist Reprod Genet. 2013 Dec;30(12):1577-81. doi: 10.1007/s10815-013-0100-4. Epub 2013 Oct 10.

Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (eSET): a national study.

Author information

1
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Women's Health, New Jersey Medical School, 185 S. Orange Ave. E-506, Newark, NJ, 07103, USA, slmarshall4@gmail.com.

Abstract

PURPOSE:

To determine which characteristics of blastocyst embryo morphology may predict clinical pregnancy and live birth rates.

METHODS:

A retrospective analysis of data from 3,151 cycles of fresh, non-donor eSET cycles from 2008 to 2009 was performed. Data were obtained from the Society for Assisted Reproductive Technologies (SART) underwent. All eSET were performed at the blastocyst stage. Main outcome measures were clinical pregnancy and live birth rates.

RESULTS:

Trophectoderm morphology, embryo stage and patient age are highly significant independent predictors of both clinical pregnancy and live birth. Neither inner cell mass morphology nor embryo grade predicted clinical pregnancy or live birth.

CONCLUSIONS:

Better trophectoderm morphology, younger patient age and further blastocyst progression all result in higher clinical pregnancy and live birth rates. Therefore, trophectoderm morphology and blastocyst stage should preferentially be used as the most important factors in choosing the best embryo for transfer.

PMID:
24114628
PMCID:
PMC3843172
DOI:
10.1007/s10815-013-0100-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center